Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

2.3K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

12.5K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
12.5K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

888
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
888
Hormonal Regulation01:33

Hormonal Regulation

30.2K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
30.2K
Hormonal Regulation01:40

Hormonal Regulation

37.4K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
37.4K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

534
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
534

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone and joint quality remains impaired in long-term controlled acromegaly: an HR-pQCT study.

Journal of the Endocrine Society·2026
Same author

Dynamic changes in body fat distribution, ectopic fat, and related metabolic improvement in response to weigt loss in obesity.

Scientific reports·2026
Same author

Predominantly genetic, intrauterine, and lifestyle aetiologies of type 2 diabetes are associated with distinct clinical presentations and risk of complications: a Danish cross-sectional and follow-up study.

EClinicalMedicine·2026
Same author

Impaired Dynamic Postural Control in People with Diabetes: An Exploratory Cross-Sectional Study Using Computerized Dynamic Posturography (Bertec).

The journal of international advanced otology·2026
Same author

COVID-19 infection prior to the onset of type 1 diabetes does not impair beta-cell function: a two-year nationwide follow-up study.

BMC endocrine disorders·2026
Same author

Dose-Response Association Between Systemic and Dermatologic Glucocorticoid Use and Type 2 Diabetes Mellitus: A Nationwide Case-Control Study.

Diabetes, obesity & metabolism·2026

Related Experiment Video

Updated: Apr 26, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

11.7K

[Hormone replacement therapy as primary prevention?].

Pia Eiken1, Peter Vestergaard, Jens-Erik Jensen

  • 1Kardiologisk, Nefrologisk, Endokrinologisk Afdeling H, Hillerød Hospital, Dyrehavevej 29, 3400 Hillerød. piei@regionh.dk.

Ugeskrift for Laeger
|August 7, 2014
PubMed
Summary
This summary is machine-generated.

Hormone replacement therapy (HRT) benefits and risks are evaluated for women under 60 or within 10 years post-menopause. This analysis aids informed decisions regarding HRT use in specific age and menopausal windows.

More Related Videos

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.7K
Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
05:32

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

2.6K

Related Experiment Videos

Last Updated: Apr 26, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

11.7K
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.7K
Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
05:32

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

2.6K

Area of Science:

  • Endocrinology
  • Women's Health
  • Pharmacology

Background:

  • Hormone replacement therapy (HRT) is a common treatment for menopausal symptoms.
  • The timing of HRT initiation relative to menopause onset influences its risk-benefit profile.
  • Understanding HRT's effects in specific age groups is crucial for clinical practice.

Purpose of the Study:

  • To comprehensively review the benefits and risks associated with hormone replacement therapy.
  • To specifically evaluate HRT outcomes when initiated before age 60 or within ten years after menopause.
  • To provide evidence-based guidance for clinicians and patients considering HRT in this demographic.

Main Methods:

  • Systematic literature review of clinical trials and observational studies.
  • Meta-analysis of relevant outcomes including cardiovascular events, cancer incidence, and symptom relief.
  • Risk-benefit assessment stratified by age at initiation and time since menopause.

Main Results:

  • HRT initiated within ten years of menopause in women under 60 generally shows a favorable benefit-risk balance.
  • Specific benefits include significant relief from vasomotor symptoms and potential bone protection.
  • Potential risks, such as increased risk of venous thromboembolism, are carefully weighed against benefits.

Conclusions:

  • Hormone replacement therapy can be safely considered for women under 60 or within ten years post-menopause.
  • The decision to use HRT should be individualized based on risk factors and symptom severity.
  • Current evidence supports HRT's role in managing menopausal symptoms when initiated during the early postmenopausal period.